48,830
edits
(→Angiomyolipoma: split out) |
(→Hereditary renal cell carcinoma: wikify) |
||
Line 350: | Line 350: | ||
#* MET proto-oncogene mutation. | #* MET proto-oncogene mutation. | ||
#* PaRCC type 1.<ref name=Ref_WMSP290>{{Ref WMSP|290}}</ref> | #* PaRCC type 1.<ref name=Ref_WMSP290>{{Ref WMSP|290}}</ref> | ||
# Hereditary leiomyomatosis and renal cell cancer:<ref name=Ref_WMSP290>{{Ref WMSP|290}}</ref> | # [[Hereditary leiomyomatosis and renal cell cancer]]:<ref name=Ref_WMSP290>{{Ref WMSP|290}}</ref> | ||
#* FH (fumarate hydratase) gene mutation.<ref name=omim136850>{{OMIM|136850}}</ref> | #* FH (fumarate hydratase) gene mutation.<ref name=omim136850>{{OMIM|136850}}</ref> | ||
#* PaRCC type 2. | #* PaRCC type 2. |
edits